Doha, Qatar: Alfardan Medical with Northwestern Medicine (AMNM), Qatar’s renowned and medically advanced ambulatory care center, recently conducted an innovative fertility preserving operation to remove a uterine polyp, which is usually associated with infertility, heavy menstruation, and anemia. The surgical procedure was performed for the first time in Qatar by Dr. Guy Fender, AMNM’s Reproductive Medicine Physician and Gynecologist, to minimize the surgical impact on the cervix and the uterine lining.

The minimally invasive technique used increases spontaneous and In vitro Fertilization (IVF) treated pregnancy success and reduces the risk of premature delivery. The value of this approach allows surgeons to avoid damaging the uterine lining caused by traditional techniques which are associated with thermal or physical trauma.

Dr. Jared Robins, Associate Professor and Medical Director at Northwestern University Feinberg School of Medicine, remarked: “Northwestern Medicine (NM) is proud to partner with Alfardan Group to bring innovative and patient centric techniques to the region – I am especially proud of this procedure because as a fertility physician, I am excited that AMNM will be able to offer the same quality of fertility care we offer at NM in Chicago.”

As one of the leading academic medical centers in U.S.A., NM provides high-quality and compassionate care, supported by research-based, advanced services and technologies for its patients.

Dr. Fender, Reproductive Medicine Physician and Gynecologist, said: “We, at AMNM, are thrilled to bring such an innovative technique to Qatar.  This way of operating on the uterus is significantly less traumatic to the cervix and endometrial lining, allowing for enhanced recovery and an early return to a normal menstrual cycle and future pregnancy.”

Proactively creating a healthy environment for future fertility is an integral part of successful pregnancies. AMNM’s Reproductive Medicine & Gynecology department provides a holistic experience in a transformative space which offers state-of-the-art individualized fertility treatment planning for couples struggling with infertility.

Reflecting on her medical experience at AMNM, the patient stated: “It was truly an amazing experience from start to finish and unlike anything I had experienced before with previous procedures. The team worked together seamlessly, and I woke up feeling great, and with exceptional pain management I was ready to go home.”

AMNM’s focus on patient centricity and service excellence nurtures personalized healthcare experiences for patients, reflecting the warmth and understanding of its expert team towards the needs and emotions that accompany infertility. Empowering patients every step of the way in their healthcare journey, the team offers counsel, comfort, and encouragement throughout the treatment plan as patients get closer to fulfilling their dreams of becoming parents.

The patient-centric care also extends to design innovation. The Reproductive Medicine & Gynecology specialty is equipped with special glue for its parquet floor and special lighting in the unit, minimizing potential harm to embryos during IVF treatment.

AMNM’s Reproductive Medicine & Gynecology team includes specialists in Gynecology, Fertility Medicine, Reproductive Endocrinology, Assisted Reproductive Technology, Genetic Counseling, and Nutrition. The expert team is dedicated to realizing patients’ individual needs, values, and preferences, aligning healthcare decisions with them, and offering the most effective and straightforward treatment plans that may lead to successful pregnancies or outcomes.

Equipped with state-of-the-art technologies, AMNM’s Reproductive Medicine & Gynecology specialty delivers both conventional and advanced treatment plans with unique protocols shared with NM in the USA. Patients suited for conventional fertility treatments are provided with procedures such as Ovulation Induction, Intrauterine Insemination (IUI) and IVF. Advances in Assisted Reproductive Technology have increased the chances of conceiving for complex cases as well. The care center’s spectrum of advanced fertility treatments includes Assisted Hatching, cutting-edge IVF technology, intracytoplasmic sperm injection, and Preimplantation genetic testing and embryo cryopreservation.

AMNM’s Reproductive Medicine & Gynecology specialty also features the latest embryoscope technology which allows safe incubation of embryos before they are transplanted into the uterus. Moreover, the specialty conducts genetic testing of embryos, in conjunction with a laboratory in the United States, for the detection of genetic diseases through preimplantation genetic testing.

Other Reproductive Medicine & Gynecology services include innovative procedures for both men and women to preserve their fertility through cryopreservation, and minimally invasive surgical procedures such as laparoscopy and hysteroscopy to treat gynecological conditions including endometriosis, fibroids, adhesions, and ovarian cysts. The department also provides a unique multi-specialty approach to conditions such as Polycystic Ovary Syndrome (PCOS).

The specialty operates on physician-to-physician referrals, working closely with other physicians in Qatar’s healthcare network to support their patients’ desired pregnancy care, monitoring them for the first eight weeks, and referring them back to their primary obstetrician.

AMNM is currently welcoming patients to high quality evidence-based medical services in Dermatology, Internal Medicine, Gastroenterology, Sleep Medicine, Reproductive Medicine and Gynecology, Orthopedics, Dentistry, Ear Nose and Throat, Physical Medicine and Rehabilitation. Highly credentialed allied health professionals specialized in Exercise Physiology, Physiotherapy, Clinical Nutrition and Diagnostic Imaging and Lab are also available.

Other AMNM medical specialties that will be introduced soon include: Ophthalmology, Plastic Surgery, and Executive Health.

AMNM’s world-class healthcare services are offered in the heart of Lusail, Qatar’s city of the future. Strategically located at the iconic Burj Alfardan, AMNM spans over six dedicated floors. Benefiting from AMNM’s interdisciplinary collaborative spirit, patients receive the highest quality of medical care from a team of outstanding doctors and friendly medical staff supported by state-of-the-art U.S.A. Food and Drug Administration approved equipment.

Members of the public are invited to book an appointment through 4004 6000 or visit amnm.com for more information.

About Alfardan Medical with Northwestern Medicine

Alfardan Medical with Northwestern Medicine (AMNM) is a high-quality, patient-centric ambulatory care center, based in Burj Alfardan, Lusail.

AMNM is an international partnership between Alfardan Group and Northwestern Medicine. Both entities share a strong vision and a set of guiding values that will power the establishment, execution, and operation of AMNM.

AMNM adopts an American patient-centric model, where the patient always comes first. The ambulatory care center houses advanced, innovative, and state-of-the-art, U.S. Food and Drug Administration (FDA) approved medical equipment, as well as a multinational medical team with significant U.S. representation.

Introducing new medical specialties to the region elevates Qatar’s position as a hub for premium medical services and medical tourism. AMNM patients will also benefit from Alfardan Group’s business offering, ranging across all sectors.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.